Fenbendazole as a Treatment for Diffuse Large B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common type of Non-Hodgkin Lymphoma (NHL) [1]. It is an aggressive disease where patients present with constitutional symptoms and rapidly enlarging lymphadenopathy, requiring urgent treatment [1]. Fenbendazole is a broad-spectrum anthelmintic that is commonly used to treat animals’ gastrointestinal parasitic infections [2,3]. Herein, we present a case of stage IVa DLBCL where patient declined chemotherapy, instead he took Fenbendazole which resulted in regression of his DLBCL.  https://austinpublishinggroup.com/hematology/fulltext/hematology-v7-id1284.php